Alpha Tau Medical Ltd. (DRTS)
Nasdaq: DRTS · Surgical & Medical Instruments & Apparatus · Jerusalem, IL · filing with the SEC since 2021
Who owns Alpha Tau Medical Ltd.
As filed with the SECHolders of 5% or more
2
Oramed Pharmaceuticals Inc. holds 20% of Ordinary shares, no par value, as its SCHEDULE 13D filed May 1, 2025 says.
Directors and officers
9
report now, of 9 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Oramed Pharmaceuticals Inc.
SCHEDULE 13D · filed May 1, 2025 · Ordinary shares, no par value
Uzi Sofer
SCHEDULE 13G · filed Jul 24, 2025 · Ordinary Shares, no par value
What DRTS reports owning in othersstakes of 5% or more, and other ties
Alpha Tau Medical Ltd. reports no stake in another company in the record.
Insider tradesForm 4
12sales
0purchases
10sales on a scheduled plan
1people selling
$1.6Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 9 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Levy Raphi | Chief Financial Officer | 12 | $1.6M | 10 | 0 | $0 |